HealthCap

About The Fund

HealthCap is a venture capital firm established in 1996 with headquarters in Stockholm, Sweden. The firm specializes in equity investments with a focus on the healthcare, life sciences, nanotechnology, mobile and information technology sectors. They are committed to investing in groundbreaking therapies, supporting innovation that can significantly impact healthcare and improve societal well-being. HealthCap's investment strategy targets companies that develop targeted therapies for rare diseases, cancers, and genetic disorders, particularly where there is a high unmet medical need. They seek to collaborate with various stakeholders, including investors, academics, their portfolio companies, patients, as well as other key players in society, to foster the life science ecosystem both locally and globally. Over the years, HealthCap has financed 129 portfolio companies, facilitated 34 pharmaceutical product approvals, and backed 47 IPOs across fourteen different markets. Their efforts have helped treat over 5 million patients worldwide. HealthCap prides itself on having medical knowledge at its core with a team of professionals that possess extensive expertise ranging from medicine to finance and biochemistry. Their investment approach is responsible and sustainable, aiming to create value for their stakeholders by challenging existing medical paradigms and exploring new treatments or potential cures for diseases. With assets under management of over $1.2 billion, HealthCap operates within the investment range of $100,000 to $5,000,000, targeting a sweet spot of around $1,500,000. They primarily engage in Seed, Startup, Early Stage, and Series B rounds, supporting companies as a Venture Capital Fund from their base at Engelbrektsplan 1, Stockholm, SE-114 34, Sweden.